SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS; A HIGH NUMBER OF PATIENTS ACHIEVE DOPPLER REMISSION AFTER 24 WEEKS

被引：0
|
作者：
Hammer, H. B. [1 ]
Hansen, I. M. J. [2 ]
Jarvinen, P. [3 ]
Leirisalo-Repo, M. [4 ,5 ]
Ziegelasch, M. [6 ]
Agular, B. [7 ]
Terslev, L. [8 ]
机构：
[1] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway
[2] Svendborg Hosp, Dept Rheumatol, Svendborg, Denmark
[3] Kiljavan Laaketutkimus, Dept Rheumatol, Kiljavan, Finland
[4] Helsinki Univ Hosp, Dept Rheumatol, Helsinki, Finland
[5] Univ Helsinki, Helsinki, Finland
[6] Univ Hosp, Dept Rheumatol, Linkoping, Sweden
[7] Roche, Dept Med, Copenhagen, Denmark
[8] Copenhagen Univ Hosp Glostrup, Ctr Rheumatol & Spinal Dis, Copenhagen, Denmark
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.3533
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0200
引用
收藏
页码：319 / 319
页数：1
相关论文
共 50 条
  • [1] DISCONTINUATION OF TOCILIZUMAB AFTER ATTAINING REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Nampei, A.
    Nagayama, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 877 - 877
  • [2] Pharmacokinetics and pharmacodynamics of tocilizumab after subcutaneous administration in patients with rheumatoid arthritis
    Zhang, Xiaoping
    Chen, Ya-Chi
    Fettner, Scott
    Rowell, Lucy
    Gott, Tatiana
    Grimsey, Paul
    Unsworth, Adam
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (08) : 620 - 630
  • [3] Weekly subcutaneous injection of tocilizumab in patients with rheumatoid arthritis
    Ito, Satoshi
    MODERN RHEUMATOLOGY, 2018, 28 (01) : 17 - 19
  • [4] Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis
    Best, Jennie H.
    Abbass, Ibrahim
    Tominna, Lenore
    Reiss, William
    AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (02): : 72 - 73
  • [5] Utilisation of subcutaneous Tocilizumab in rheumatoid arthritis patients in Grampian
    Philobos, M.
    Davidson, A.
    Dospinescu, P.
    SCOTTISH MEDICAL JOURNAL, 2019, 64 (03) : NP39 - NP39
  • [6] SUBCUTANEOUS TOCILIZUMAB AS MONOTHERAPY OR IN COMBINATION WITH A CSDMARD IN PATIENTS WITH RHEUMATOID ARTHRITIS: 24 WEEKS RESULTS OF THE FRENCH PHASE IIIB STUDY, "TOSCA"
    Fautrel, B.
    Senbel, E.
    Vittecoq, O.
    Rist, S.
    Combe, B.
    Schaeverbeke, T.
    Liote, F.
    Flipo, R-M.
    Baffie, C.
    Pau, D.
    Fraga, E. Conde Da Silva
    Pinta, A.
    Gaudin, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1186 - 1187
  • [7] THE LENGHT OF REMISSION AND RATE OF RELAPSE AFTER TOCILIZUMAB WITHDRAWAL IN RHEUMATOID ARTHRITIS PATIENTS
    Aguilar-Lozano, L.
    Padilla-Ibarra, J.
    Sandoval-Castro, C.
    Castillo-Ortiz, J. D.
    Morales-Torres, J.
    Hernandez, C.
    Burgos-Vargas, R.
    Pacheco-Tena, C.
    Ramos-Remus, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 69 - 70
  • [8] Dose Modification of Subcutaneous Tocilizumab in Patients with Rheumatoid Arthritis Response
    Punekar, Rajeshwari
    Choi, Jeannie
    Boklage, Susan H.
    Iglesias-Rodriguez, Melitza
    Nola, Kamala
    AMERICAN HEALTH AND DRUG BENEFITS, 2020, 13 (02): : 73 - 73
  • [9] Sustained Clinical Remission and Rate of Relapse After Tocilizumab Withdrawal in Patients with Rheumatoid Arthritis
    Aguilar-Lozano, Luis
    Dionisio Castillo-Ortiz, Jose
    Vargas-Serafin, Cesar
    Morales-Torres, Jorge
    Sanchez-Ortiz, Adriana
    Sandoval-Castro, Carlos
    Padilla-Ibarra, Jorge
    Hernandez-Cuevas, Claudia
    Ramos-Remus, Cesar
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (07) : 1069 - 1073
  • [10] Clinical Remission and Rate of Relapse After Tocilizumab Withdrawal in Rheumatoid Arthritis Patients.
    Vargas-Serafin, Cesar
    Aguilar-Lozano, Luis
    Padilla-Ibarra, Jorge
    Sandoval-Castro, Carlos
    Dionisio Castillo-Ortiz, Jose
    Morales-Torres, Jorge
    Hernandez, Claudia
    Ramos-Remus, Cesar
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S193 - S193
12345